OvaScience Inc. (Nasdaq: OVAS) does not expect to meet its 2015 goal of 1,000 AUGMENT treatment cycles. The stock price plummeted $5.95 to close at $8.57.
OvaScience will not meet goal
September 29, 2015 at 19:33 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.